EN
HI
Summary
As of 11 Nov, 2026, CORONA Remedies stock price is ₹2539.4. During the trading session, the stock has moved between an intraday low of ₹2500.30 and an intraday high of ₹2719.30. Over the last 52 weeks, CORONA Remedies has traded between ₹1336.60 and ₹2719.30.
The stock has recorded a trading volume of 1,66,759 shares,. Its Average Traded Price (ATP) is ₹2612.55, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹2539.40.
CORONA Remedies has an upper circuit limit of ₹3047.20 and a lower circuit limit of ₹2031.60. The total value traded stands at ₹43.57 CR, and the delivery percentage for the day is 22.72%.
The stock is currently traded with a market lot size of 1. CORONA Remedies also offers a dividend yield of 0.39%.
CORONA Remedies Share Price Chart
CORONA Remedies Share Key Metrics
Volume
1.67 L
Market Cap
15530.99 CR
LTQ@LTP
2@2539.40
ATP
2612.55
Var Margin
14.22 %
Circuit Range
2031.6-3047.2
Delivery %
22.72 %
Value
43.57 CR
ASM/GSM
No
Market Lot
1
CORONA Remedies Fundamentals
P/E Ratio
75.06
P/B Ratio
19.3
Div. Yield
0.39
Sector P/E
40.97
Sector P/B
3.85
Sec. Div. Yield
0.53
CORONA Remedies Resistance and Support
Pivot 2586.33
Resistance
First Resistance
2672.36
Second Resistance
2805.33
Third Resistance
2891.36
Support
First Support
2453.36
Second Support
2367.33
Third Support
2234.36
CORONA Remedies Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Nov 09 2026 | 2525 | 2539.39 | 0.21% | 2719.3 | 2500.3 |
| Sun Nov 08 2026 | 2479 | 2534.19 | 3.81% | 2550 | 2478.89 |
| Fri Nov 06 2026 | 2372.6 | 2441.1 | 2.58% | 2584 | 2358.1 |
CORONA Remedies Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-30 | Quarterly Results |
| 2026-07-31 | Quarterly Results |
| 2026-05-11 | Audited Results & Final Dividend |
| 2026-02-02 | Quarterly Results |
| 2026-01-02 | Quarterly Results |
CORONA Remedies News
Corona Remedies Ltd - 544644 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Corona Remedies announced its Q2 FY27 results with revenue growing 22.2% YoY to Rs.441.2 crore and net profit up 15.3% YoY to Rs.60.3 crore. The company also received ANVISA GMP certification for its Bhayla manufacturing facility.
Oct 30 2026 18:46:55
Corona Remedies Ltd - 544644 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Corona Remedies has received ANVISA GMP certification from Brazil for its manufacturing facility at Bhayla, Ahmedabad. The approval covers both Oral Solid Dosage (OSD) and Women's Hormone production lines, marking its third major international GMP accreditation.
Oct 22 2026 18:42:24
Read More
CORONA Remedies Management
| Name | Position |
|---|---|
| Kirtikumar Laxmidas Mehta | Chairman |
| Niravkumar Kirtikumar Mehta | Managing Director & Chief Executive Officer |
CORONA Remedies Similar Stocks
Cohance Lifesciences Ltd.
443.65
0.00 (0.00%)
Dr. Agarwal's Health Care Ltd.
537.30
0.00 (0.00%)
Poly Medicure Ltd.
1614.30
0.00 (0.00%)
Natco Pharma Ltd.
804.35
0.00 (0.00%)
Molbio Diagnostics Ltd.
1336.00
0.00 (0.00%)
Vijaya Diagnostic Centre Ltd.
1478.30
0.00 (0.00%)
Jubilant Pharmova Ltd.
966.00
0.00 (0.00%)
Marksans Pharma Ltd.
308.75
0.00 (0.00%)
Sudeep Pharma Ltd.
1210.30
0.00 (0.00%)
Rainbow Children's Medicare Ltd.
1275.20
0.00 (0.00%)
CORONA Remedies FAQs
The Buying Price of CORONA Remedies share is 2539.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy CORONA Remedies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for CORONA Remedies, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of CORONA Remedies shares is 75.06. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio CORONA Remedies shares is 19.3. Useful to assess the stock's value relative to its book value.
To assess CORONA Remedies’s valuation compare Sector P/E, P/B which are 40.97 & 3.85 with sector averages, along with growth rates and financial metrics.
The Market Cap of CORONA Remedies is 15530.99 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of CORONA Remedies share price is 2719.30 & 1336.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
CORONA Remedies belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in CORONA
